FDA Lifts Clinical Holds On Anemia Compounds Under Development By Astellas/FibroGen

FDA approves protocols proposed by FibroGen to resume Phase II trials of FG-2216 and FG-4592.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet